Photo from Zev Wainberg from X
Jun 29, 2024, 10:55
Zev Wainberg discussing the 3-year OS data from the TOPAZ-1 trial
Lorenza Rimassa, Associate Professor of Medical Oncology at HUNIMED, shared on X:
“Zev Wainberg discussing the 3-year OS data from the TOPAZ-1 trial in biliary tract cancer and the OPTIMIZE-1 in pancreatic cancer. Which are the open questions and future perspectives?”
Source: Lorenza Rimassa/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 12:13
Nov 13, 2024, 11:52
Nov 13, 2024, 11:48
Nov 13, 2024, 11:44
Nov 13, 2024, 11:39
Nov 13, 2024, 11:30
Nov 13, 2024, 11:25
Nov 13, 2024, 11:10
Nov 13, 2024, 10:59